Article

FDA hires director for Office of Drug Safety

Gerald Dal Pan, director of the FDA's Division of Surveillance, Research, and Communication Support (DSRCS), will become the director of the FDA's Office of Drug Safety.

In that role, he will run the agency's high-profile postmarketing drug safety program. He also will work closely with stakeholders inside and outside the federal government, including the Drug Safety Oversight Board and Congress; develop and maintain international and national contacts with regulators; implement policies and initiatives related to adverse drug events and the MedWatch program; and represent the FDA and its Center for Drug Evaluation of Research in scientific and regulatory matters related to drug safety.

Dal Pan has been with the FDA since 2000. He was first hired as a medical reviewer in the Division of Anesthetic Critical Care and Addiction Drug Products. He became director of DSRCS in 2003.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.